Nasdaq smmt.

Mar 9, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Nasdaq smmt. Things To Know About Nasdaq smmt.

Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ...Oxford, UK, and Cambridge, MA, US, 9 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announces that it has demonstrated the potential of its DDS-04 series of new class ...

During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.08 million, with the beta value of the company hitting -1.02. At the last check today, the stock’s price was $1.65, reflecting an intraday loss of -9.32% or -$0.18. The 52-week high for the SMMT share is $5.Oxford, UK, and Cambridge, MA, US, 14 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces two presentations ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Recognises C. difficile Awareness Month Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole ...

Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...Oxford, UK, and Cambridge, MA, US, 23 January 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that the Biomedical ...Oxford, UK, and Cambridge, MA, US, 6 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it achieved the first milestone under its license and collaboration ...CAMBRIDGE, Mass. and OXFORD, United Kingdom, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for ...Web

Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.

Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week Read full article Simply Wall StOxford, UK, and Cambridge, MA, US, 14 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today presented in vivo proof of concept ...Follow. Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its ...In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...há 2 dias ... (NASDAQ:SMMT – Get Free Report)'s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at ...Oxford, UK, and Cambridge, MA, US, 5 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in ...

Webull offers Summit Therapeutics Inc stock information, including NASDAQ: SMMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMMT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for …Webhá 2 dias ... (NASDAQ:SMMT – Get Free Report)'s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at ...OXFORD, United Kingdom, April 26, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Summit Therapeutics Inc. Common Stock (SMMT) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...

Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics (NASDAQ:SMMT) is a project of Bob Duggan of Pharmacyclics fame. This is what keeps our hopes in the future of this company alive, even though the company keeps changing so much ...CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily …Webull offers Summit Therapeutics Inc stock information, including NASDAQ: SMMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMMT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for …WebSummit Therapeutics Inc. Common Stock (SMMT) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18.Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...

Posted by Defense World Staff on Dec 3rd, 2023. Shares of Summit Therapeutics Inc. ( NASDAQ:SMMT – Get Free Report) were down 3.9% on Friday . The company traded as low as $1.94 and last traded ...Web

Mar 24, 2021 · Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of ...

Aug 2, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California , and we have additional offices in Oxford, UK ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Menlo Park, California, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it is nearing the previously-announced ...Windtree Therapeutics, Inc. (NASDAQ:WINT), Kala Pharmaceuticals, Inc. (NASDAQ:KALA), Summit Therapeutics Inc. (NASDAQ:SMMT), and GreenLight Biosciences Holdings (NASDAQ:GRNA) are some great stocks ...WebNov 7, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 2,045.6% in December marketbeat.com - December 28 at 1:08 PM: Summit Therapeutics Inc.'s (NASDAQ:SMMT) CEO Robert Duggan is the most upbeat insider, and their holdings increased by 431% last week finance.yahoo.com - December 9 at 2:06 PM: marketbeat.com - December 9 at 10:28 AM Summit Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "SMMT". What is Summit Therapeutics's primary industry? Company operates in the ...Summit Therapeutics Inc. Common Stock (SMMT) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Cambridge, MA, July 12, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying three preeminent ePosters at the prestigious 31st ...Web

At A Glance. In a significant shift, Summit Therapeutics ( NASDAQ: SMMT) bets big on oncology with its promising bispecific antibody, ivonescimab, which is set to enter Phase III trials for non ...What happened. Shares of Summit Therapeutics (SMMT 1.00%) were skyrocketing 371.8% higher this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence ...During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.99 million, with the beta value of the company hitting -1.00. At the end of the trading day, the stock’s price was $2.03, reflecting an intraday gain of 4.10% or $0.08. The 52-week high for the SMMT share is $5 ...Hedge fund interest in Summit Therapeutics PLC (NASDAQ:SMMT) shares was flat at the end of last quarter. This is usually a negative indicator. This is usually a negative indicator.Instagram:https://instagram. best stock trading books for beginnerstop precious metal mutual fundsis paypal a good stock to buystock lockheed martin Oct 26, 2023 · MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and ... Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.Web space x stock pricesbest server host minecraft During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.08 million, with the beta value of the company hitting -1.02. At the last check today, the stock’s price was $1.65, reflecting an intraday loss of -9.32% or -$0.18. The 52-week high for the SMMT share is $5.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK. alsk Oct 26, 2023 · MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and ... Webull offers Summit Therapeutics Inc stock information, including NASDAQ: SMMT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SMMT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for …WebStocks that have clustered insider purchases in March include The Charles Schwab Corporation (NYSE:SCHW), Keurig Dr Pepper Inc.(NASDAQ:KDP), and Summit Therapeutics PLC (NASDAQ:SMMT). 7. GuruFocusWeb